Griffin C - Search Results

1

Impact of prolonged infusions of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia.

Gore SD, Weng LJ, Figg WD, Zhai S, Donehower RC, Dover G, Grever MR, Griffin C, Grochow LB, Hawkins A, Burks K, Zabelena Y, Miller CB. Gore SD, et al. Among authors: griffin c. Clin Cancer Res. 2002 Apr;8(4):963-70. Clin Cancer Res. 2002. PMID: 11948101 Clinical Trial.

2

A phase II "window" study of topotecan in untreated patients with high risk adult acute lymphoblastic leukemia.

Gore SD, Rowinsky EK, Miller CB, Griffin C, Chen TL, Borowitz M, Donehower RC, Burks KL, Armstrong DK, Burke PJ, Grever MR, Kaufmann SH. Gore SD, et al. Among authors: griffin c. Clin Cancer Res. 1998 Nov;4(11):2677-89. Clin Cancer Res. 1998. PMID: 9829730 Clinical Trial.

3

Impact of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia.

Gore SD, Weng LJ, Zhai S, Figg WD, Donehower RC, Dover GJ, Grever M, Griffin CA, Grochow LB, Rowinsky EK, Zabalena Y, Hawkins AL, Burks K, Miller CB. Gore SD, et al. Among authors: griffin ca. Clin Cancer Res. 2001 Aug;7(8):2330-9. Clin Cancer Res. 2001. PMID: 11489809 Clinical Trial.

4

Effects of the differentiating agent hexamethylene bisacetamide on normal and myelodysplastic hematopoietic progenitors.

Rowinsky EK, Donehower RC, Spivak JL, Burke PJ, Griffin CA, Jones RJ. Rowinsky EK, et al. Among authors: griffin ca. J Natl Cancer Inst. 1990 Dec 19;82(24):1926-31. doi: 10.1093/jnci/82.24.1926. J Natl Cancer Inst. 1990. PMID: 2250314

5

High mobility group protein I(Y): a candidate architectural protein for chromosomal rearrangements in prostate cancer cells.

Takaha N, Hawkins AL, Griffin CA, Isaacs WB, Coffey DS. Takaha N, et al. Cancer Res. 2002 Feb 1;62(3):647-51. Cancer Res. 2002. PMID: 11830513

6

Evolution of a near-triploid karyotype in a secondary erythroleukemia.

Hawkins AL, Miller CB, Burke PJ, Griffin CA. Hawkins AL, et al. Among authors: griffin ca. Cancer Genet Cytogenet. 1991 Jul 1;54(1):11-20. doi: 10.1016/0165-4608(91)90024-o. Cancer Genet Cytogenet. 1991. PMID: 2065305

7

Growth factor-mediated terminal differentiation of chronic myeloid leukemia.

Bedi A, Griffin CA, Barber JP, Vala MS, Hawkins AL, Sharkis SJ, Zehnbauer BA, Jones RJ. Bedi A, et al. Among authors: griffin ca. Cancer Res. 1994 Nov 1;54(21):5535-8. Cancer Res. 1994. PMID: 7923192

8

BCR/ABL rearrangement in two cases of Philadelphia chromosome negative chronic myeloid leukemia: deletion on the derivative chromosome 9 may or not be present.

Batista DA, Hawkins A, Murphy KM, Griffin CA. Batista DA, et al. Cancer Genet Cytogenet. 2005 Dec;163(2):164-7. doi: 10.1016/j.cancergencyto.2005.04.021. Cancer Genet Cytogenet. 2005. PMID: 16337861

9

Chromosome abnormalities in pediatric brain tumors.

Griffin CA, Hawkins AL, Packer RJ, Rorke LB, Emanuel BS. Griffin CA, et al. Cancer Res. 1988 Jan 1;48(1):175-80. Cancer Res. 1988. PMID: 3334992

10

Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11.

Rinker-Schaeffer CW, Hawkins AL, Ru N, Dong J, Stoica G, Griffin CA, Ichikawa T, Barrett JC, Isaacs JT. Rinker-Schaeffer CW, et al. Among authors: griffin ca. Cancer Res. 1994 Dec 1;54(23):6249-56. Cancer Res. 1994. PMID: 7954474

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,273 results

Search Page

Filters